Fundraising Fox
/Investor DB
Sign in

Windham Capital Partners — 2015 Investments

3 investments dated 2015 · listed companies and verified rows first · show all

GlySensglysens.comDec 2015

HealthtechSan Diego, US

JOSEPH Y. LUCISANO(CHIEF TECHNOLOGY OFFICER)WILLIAM H. MARKLE(PRESIDENT AND CEO)in

BoardADAM E. FINE(Director)inSAMUEL V. GOEKJIAN(Director)ROBERT L. ENGLER(Director)ORVILLE G. KOLTERMAN(Director)

Nuelleaytubio.comin𝕏Apr 2015

A specialty pharmaceutical company focused on developing and commercializing novel therapeutics for central nervous system conditions, serving patients and healthcare providers.

BiotechHealthtechMedical DevicesMountain View, US

Joshua Makower(Executive Officer, Director)Stefano Curti(Executive Officer, Director)

BoardDavis Yang(Director)John Nehra(Director)Yi Li(Director)Ryan Drant(Director)

Co-investorsRuvento Ventures Pte Ltd.

WellDocwelldoc.comin𝕏Jul 2015

Welldoc develops an AI-driven digital health platform focused on cardiometabolic disease management, providing personalized treatment solutions for patients with diabetes and related conditions.

AI & Machine LearningDigital HealthHealthtechBaltimore, US

Ryan Sysko(Executive Officer, Director)inSuzanne Clough(Executive Officer)inKevin McRaith(President and CEO)inAnand Iyer(Chief AI Officer)inChris Bergstrom(Executive Officer)in

BoardTerry Lierman(Director)

Co-investorsMerck Global Health Innovation FundSamsung VenturesAsset Management CompanyDigiTx Partners LLCExcel Venture ManagementMSD Global Health Innovation Fund+2 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.